Search
for
Sort by
Research 30 of 59
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Guidelines for the Use of Acitretin in Psoriasis
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Efficacy and Safety of Biologic Therapies for Treatment of Psoriasis: A Systematic Review and Observational Meta-Analysis
- Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab
- 308-nm Excimer Lamp vs. Combination of 308-nm Excimer Lamp and 10% Liquor Carbonis Detergens in Patients With Scalp Psoriasis: A Randomized, Single-Blinded, Controlled Trial
- Integrating systemic agents in clinic-based practice
- Dermoscopy of an osteonevus of Nanta
- Efficacy of tofacitinib in pediatric alopecia universalis
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings
- Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up
- Lack of Response to Laser Comb in Spontaneous and Graft-Induced Alopecia Areata in C3H/HeJ Mice
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Janus Kinase inhibitors in dermatology: a review
- Integrating Psychodermatology and Platelet-Rich Plasma Therapy in Various Dermatological Conditions: A Narrative Review
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Interventions for nail psoriasis
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- The role of diet in the management of psoriasis: a scoping review
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- An Update on Scalp Psoriasis
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report
- The Role of Janus Kinase Inhibitors in Dermatology
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment